Minireviews
Copyright ©The Author(s) 2015.
World J Clin Infect Dis. Feb 25, 2015; 5(1): 1-10
Published online Feb 25, 2015. doi: 10.5495/wjcid.v5.i1.1
Table 2 Pneumococcal vaccination studies in kidney transplantation in adult recipients
Ref.NTime since transplantVaccineTechniqueResponse to immunizationLong term immune response
Silberman et al[59]27 KT vs 24 healthy adults7-108 mo14-valentIndirect hemagglutination4-fold increase in titers, equivalent to controlsNot studied
Marrie et al[60]63 KT vs 8 healthy adults3-99 mo14-valentRIA2.8-fold increase in titers in KT vs 3.4-fold in controlsGMT in KT: 872 ng N/mL post-vaccine 659 ng N/mL at 12 mo
Cosio et al[61]25 KT (14 asplenia) vs 14 healthy adults3-118 mo14-valentRIA2-fold increase in titers in 93% of 14 healthy adults vs 78% of 14 splenectomized KT and 55% of 11 non-splenectomized KT patientsNot studied
Linneman et al[62,63]104 KT (79 asplenia) vs 33 patients in hemodialysisNo data14-valentRIA1.4-fold increase in antibody titers: 91%GMT post-vaccine with lower response in splenectomized KT vs non-splenectomized KT patients (394 vs 626 ng N/mL, P < 0.05) GMT post-vaccine with lower response in KT patients before 6 mo after transplant vs hemodialysis patients (303 vs 592 ng N/mL, P < 0.05)GMT at 24 mo in 33 KT: 932 ng N/mL post-vaccine 385 ng N/mL at 24 mo 536 ng N/mL at revaccination
Arnold et al[64]75 KT (32 asplenia) vs 60 healthy controls> 12 mo14-valentSerum opsonizing antibody2-fold increase in titers to serotypes 12F and 14 No differences in splenectomized vs non-splenectomized KT recipientsNot studied
Rytel et al[65]61 KT (57 asplenia) vs 23 patients in dialysis vs 9 healthy controls> 6 mo14-valentRIAEquivalent protective GMT titers vs controlsEquivalent at 1, 2, and 3.5 yr vs controls
Kazancioglu et al[69]21 KT vs 25 healthy controls> 2 moPPV23ELISAProtective response to vaccination (40% increases in the antibody concentration) in 95.2% of KT at 1.5 and 3 mo after vaccinationNot studied
Kumar et al[78,79]30 KT (PPV23) vs 30 KT (PCV7)3 mo-3 yrPPV23 vs PCV7ELISA, OPAResponse to at least 1 serotype: no significant differences in antibody titers between PPV23 and PVC7, both using ELISA (53.3% vs 73.3%) and OPA (83.3% vs 80%)Vaccine responses decline significantly after 3 yr and conjugate vaccine does not improve the durability of response